Compass Wealth Management’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Compass Wealth Management’s Portfolio ORTX Stock Details ORTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-9	Closed	-$149	–	396
2023 Q4	$149	Buy	+9	New	+$142	﹤0.01%	381

Compass Wealth Management's ORTX Position: Q1 2024 in Review

Compass Wealth Management sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q1 2024, closing a stake of 9 shares — an estimated $149 sold.

Compass Wealth Management first reported a position in ORTX in Q4 2023 and held it in 1 quarter. The position peaked at $149 in Q4 2023. 0 funds tracked by Wall St. Rank hold ORTX as of Q1 2024.

Compass Wealth Management reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q1 2024 after selling out during the quarter.
Compass Wealth Management sold 9 Orchard Therapeutics plc American Depositary Shares shares in Q1 2024, an estimated $149.
Compass Wealth Management first reported a position in Orchard Therapeutics plc American Depositary Shares in Q4 2023 and held it in 1 quarter.
Compass Wealth Management's Orchard Therapeutics plc American Depositary Shares position peaked at $149 in Q4 2023.
0 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q1 2024.

Based on Compass Wealth Management's 13F filing for Q1 2024, filed 5 Apr 2024.